Indication

Trigeminal neuralgia

Trigeminal neuralgia is a chronic neuropathic pain disorder affecting the sensory distribution of the fifth cranial nerve. Read more about Trigeminal neuralgia

60 drugs 41 manufacturers

Advertisement

Drugs that treat it

Common Trigeminal neuralgia therapies.

Showing 1–9 of 60 drugs

CARBAMAZEPINE

ANTICONVULSANTS·TONIC-CLONIC EPILEPSY·+4
TORRENT PHARMAC

LEQVIO (carbamazepine)

ANTIHYPERLIPIDEMIC - PCSK9 INHIBITORS·TONIC-CLONIC EPILEPSY·+4
Novartis Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Trigeminal neuralgia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Trigeminal neuralgia.

Trigeminal neuralgia is a chronic neuropathic pain disorder affecting the sensory distribution of the fifth cranial nerve.

It predominantly arises in adults over age 50 and is characterized by sudden, severe, unilateral paroxysms of lancinating or electric-shock-like facial pain, frequently provoked by innocuous tactile stimuli such as light touch, chewing, talking, or washing the face.

The condition most commonly stems from neurovascular compression of the trigeminal nerve root entry zone leading to focal demyelination, though it may also develop secondary to structural lesions or central demyelinating diseases such as multiple sclerosis.

Personalize your experience

Follow Trigeminal neuralgia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it